Taken together, PEA and its congeners could represent an innovative therapeutic strategy during the management of blended neuropathies. Bias assessments for each included analyze are summarized in Figure two and graphed in combination in Figure 3. Only one review was scored as high chance of bias from the classification https://whatischronicpain67414.myparisblog.com/30954974/not-known-details-about-palmitoylethanolamide